Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Journal of Clinical Investigation

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/eci.12420PMID 25682967PMCID PMC4903079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study.

  2014cited by this paper
• Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.

  2014cited by this paper
• miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells

  2013cited by this paper
• Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1

  2013cited by this paper
• Serum microRNAs levels in primary focal segmental glomerulosclerosis

  2013cited by this paper
• Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin.

  2013cited by this paper
• Epigenetics of progression of chronic kidney disease: fact or fantasy?

  2013cited by this paper
• The microRNA-342-5p Fosters Inflammatory Macrophage Activation Through an Akt1- and microRNA-155–Dependent Pathway During Atherosclerosis

  2013cited by this paper
• Recent Progress in the Pathophysiology and Treatment of FSGS Recurrence

  2013cited by this paper
• Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.

  2012cited by this paper
• Circulating levels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease

  2012cited by this paper
• CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGF&bgr; type II receptor with implications for nephropathic cell phenotypes

  2012cited by this paper
• miRNA-34c regulates Notch signaling during bone development.

  2012cited by this paper
• Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.

  2012cited by this paper
• Circulating miR-210 predicts survival in critically ill patients with acute kidney injury.

  2011cited by this paper
• Circulating microRNA expression is reduced in chronic kidney disease.

  2011cited by this paper
• Role of microRNAs in endothelial cell pathophysiology.

  2011cited by this paper
• Pervasive roles of microRNAs in cardiovascular biology

  2011cited by this paper
• Comparison of different miR-21 inhibitor chemistries in a cardiac disease model.

  2011cited by this paper
• Gene Expression Profiling Reveals Renin mRNA Overexpression in Human Hypertensive Kidneys and a Role for MicroRNAs

  2011cited by this paper
• Elevated Levels of miR-146a and miR-155 in Kidney Biopsy and Urine from Patients with IgA Nephropathy

  2011cited by this paper
• A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.

  2010cited by this paper
• Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis.

  2010cited by this paper
• TLR2 plays a role in the activation of human resident renal stem/progenitor cells

  2010cited by this paper
• Identification of Unique MicroRNA Signature Associated with Lupus Nephritis

  2010cited by this paper
• Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.

  2010cited by this paper
• Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening

  2009cited by this paper
• MicroRNA expression profiles predictive of human renal allograft status

  2009cited by this paper
• MicroRNAs and their role in progressive kidney diseases.

  2009cited by this paper
• Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury.

  2009cited by this paper
• An update on the treatment options for focal segmental glomerulosclerosis

  2009cited by this paper
• The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells

  2009cited by this paper
• MicroRNAs and the kidney: coming of age

  2009cited by this paper
• MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases

  2009cited by this paper
• Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis.

  2008cited by this paper
• Mesenchymal stem cells in acute kidney injury.

  2008cited by this paper
• Ectopic notch activation in developing podocytes causes glomerulosclerosis.

  2008cited by this paper
• MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis.

  2008cited by this paper
• MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

  2008cited by this paper
• Transrenal Nucleic Acids: From Proof of Principle to Clinical Tests

  2008cited by this paper
• The Notch pathway in podocytes plays a role in the development of glomerular disease

  2008cited by this paper
• Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis.

  2006cited by this paper
• miRBase: the microRNA sequence database.

  2006cited by this paper
• Epithelial-mesenchymal transition and its implications for fibrosis.

  2003cited by this paper
• In situ evaluation of podocin in normal and glomerular diseases.

  2003cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Expression of nephrin in pediatric kidney diseases.

  2001cited by this paper
• Long-term outcome in children and adults with classic focal segmental glomerulosclerosis.

  1998cited by this paper
• Focal and segmental glomerulosclerosis: analogies to atherosclerosis.

  1988cited by this paper

• miRNAs in Glomerular Diseases: From Pathogenic Insight to Therapeutic Potential: A Narrative Review

  2026cites this paper
• Multiple roles of microRNA-155 in chronic kidney diseases

  2025cites this paper
• Circulating small extracellular vesicles in chronic kidney disease and vascular calcification: “Tiny packages with big biological mission”

  2025cites this paper
• Study on the expression levels and correlation of miRNA-30a and Runx2 protein macromolecule in renal osteodystrophy based on biosensor

  2025cites this paper
• Emerging roles of non-coding RNAs in idiopathic nephrotic syndrome: a narrative review

  2025cites this paper
• Urinary Exosomes in Nephrology: A New Frontier for Diagnosis and Prognosis of Kidney Diseases

  2025cites this paper
• Emerging roles of exosomes in the diagnosis and treatment of kidney diseases

  2025cites this paper
• Recent Advances in miRNA Biomarkers for Diagnosis and Prognosis of Focal Segmental Glomerulosclerosis

  2025influential citation
• Advances in focal segmental glomerulosclerosis research: genetic causes to non-coding RNAs

  2025cites this paper
• Urine Extracellular Vesicle miRNA Changes Induced by Vicadrostat with/Without Empagliflozin in Patients with Chronic Kidney Disease

  2025cites this paper
• A Systematic Review and Meta-Analysis of microRNA Profiling Studies in Chronic Kidney Diseases

  2024cites this paper
• MicroRNA Expression and Target Prediction in Children with Nephrotic Syndrome

  2024cites this paper
• Identification of Plasma hsa_circ_0001230 and hsa_circ_0023879 as Potential Novel Biomarkers for Focal Segmental Glomerulosclerosis and circRNA-miRNA-mRNA Network Analysis

  2024cites this paper
• Understanding the Roles of Non-coding RNAs and Exosomal Non-Coding RNAs in Diabetic Nephropathy.

  2024cites this paper
• Urinary podocyte markers in diabetic kidney disease

  2024cites this paper
• Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics

  2023cites this paper
• MicroRNA‐126 in dogs with immune complex‐mediated glomerulonephritis

  2023cites this paper
• Urinary extracellular vesicles in childhood kidney diseases

  2023cites this paper
• Extracellular Vesicle MicroRNA in the Kidney.

  2023cites this paper
• Systemic lupus erythematosus: From non-coding RNAs to exosomal non-coding RNAs.

  2023cites this paper
• Epigenetic Mechanisms and Nephrotic Syndrome: A Systematic Review

  2023cites this paper
• Molecular profiling of urinary extracellular vesicles in chronic kidney disease and renal fibrosis

  2023cites this paper
• Urinary Extracellular Vesicles in Chronic Kidney Disease: From Bench to Bedside?

  2023cites this paper
• Biomarkers to Monitor Adherence to Gluten-Free Diet by Celiac Disease Patients: Gluten Immunogenic Peptides and Urinary miRNAs

  2022cites this paper
• Glomerular Endothelial Cell-Derived miR-200c Impairs Glomerular Homeostasis by Targeting Podocyte VEGF-A

  2022cites this paper
• Extracellular vesicles from focal segmental glomerulosclerosis pediatric patients induce STAT3 activation and mesangial cell proliferation

  2022cites this paper
• The clinical significance of circulating microRNA-21 in patients with IgA nephropathy

  2022cites this paper
• What do we actually know about exosomal microRNAs in kidney diseases?

  2022cites this paper
• Protein Glycosylation in Urine as a Biomarker of Diseases.

  2022cites this paper
• Pathogenic Role of MicroRNA Dysregulation in Podocytopathies

  2022cites this paper
• Recent findings on the role of microRNAs in genetic kidney diseases

  2022cites this paper
• Circulating miRNAs in extracellular vesicles related to treatment response in patients with idiopathic membranous nephropathy

  2022cites this paper
• Decoding the Mechanism behind the Pathogenesis of the Focal Segmental Glomerulosclerosis

  2022cites this paper
• Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy

  2022cites this paper
• Non-Coding RNA and Diabetic Kidney Disease

  2021cites this paper
• Roles of microRNAs in renal disorders related to primary podocyte dysfunction.

  2021cites this paper
• MicroRNAs in childhood nephrotic syndrome

  2021influential citation
• Urinary podocyte markers in kidney diseases.

  2021cites this paper
• Higher Urine Exosomal miR-193a Is Associated With a Higher Probability of Primary Focal Segmental Glomerulosclerosis and an Increased Risk of Poor Prognosis Among Children With Nephrotic Syndrome

  2021cites this paper
• Targeting the MicroRNAs in Exosome: A Potential Therapeutic Strategy for Alleviation of Diabetes-Related Cardiovascular Complication.

  2021cites this paper
• Exosomes: Emerging Therapy Delivery Tools and Biomarkers for Kidney Diseases

  2021cites this paper
• Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease

  2021cites this paper
• Role of autophagy and evaluation the effects of microRNAs 214, 312, 34c and prorenin receptor in a rat model of focal segmental glomerulosclerosis.

  2021cites this paper
• Plasma microRNAs profiling distinguishes patients with frontotemporal dementia from healthy subjects

  2021cites this paper
• Extracellular vesicles: a novel window into kidney function and disease

  2020cites this paper
• Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?

  2020influential citation
• RNA Interference and CRISPR Technologies: Technical Advances and New Therapeutic Opportunities

  2020cites this paper
• Urinary MicroRNAs as Emerging Class of Noninvasive Biomarkers.

  2020cites this paper
• The Urinary Exosomal miRNA Expression Profile is Predictive of Clinical Response in Lupus Nephritis

  2020cites this paper
• Linagliptin and telmisartan induced effects on renal and urinary exosomal miRNA expression in rats with 5/6 nephrectomy

  2020cites this paper
• Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases

  2020cites this paper
• Dicer and Drosha expression in patients with nephrotic syndrome.

  2020cites this paper
• MiRNAs as potential biomarker of kidney diseases: A review

  2020cites this paper
• microRNA in Extracellular Vesicles Released by Damaged Podocytes Promote Apoptosis of Renal Tubular Epithelial Cells

  2020influential citation
• Extracellular vesicles carrying miRNAs in kidney diseases: a systemic review

  2020influential citation
• Exosomal miR-34b inhibits proliferation and the epithelial-mesenchymal transition by targeting Notch2 in ovarian cancer

  2020cites this paper
• Expression Levels of miR-30c and miR-186 in Adult Patients with Membranous Glomerulonephritis and Focal Segmental Glomerulosclerosis

  2020cites this paper
• Potential role of ACE2-related microRNAs in COVID-19-associated nephropathy

  2020influential citation
• Identification and analysis of urine-derived exosomal miRNAs and BDNF

  2020cites this paper
• Circulating exosomal microRNAs as emerging non‐invasive clinical biomarkers in heart failure: Mega bio‐roles of a nano bio‐particle

  2020cites this paper
• Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers

  2020cites this paper
• Utility of the “omics” in kidney disease: Methods of analysis, sampling considerations, and technical approaches in renal biomarkers

  2020cites this paper
• Extracellular Vesicles from Adipose Tissue Stem Cells in Diabetes and Associated Cardiovascular Disease; Pathobiological Impact and Therapeutic Potential

  2020cites this paper
• Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology

  2020cites this paper
• MicroRNAs as Biomarkers for Nephrotic Syndrome

  2020influential citation
• Unbiased RNA-Seq-driven identification and validation of reference genes for quantitative RT-PCR analyses of pooled cancer exosomes

  2020cites this paper
• Unbiased RNA-Seq-driven identification and validation of reference 1 genes for quantitative RT-PCR analyses of cancer exosomes 2

  2020cites this paper
• The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy

  2019cites this paper
• Molecular stratification of idiopathic nephrotic syndrome

  2019cites this paper
• Plasma microRNA profiling distinguishes patients with frontotemporal dementia from healthy subjects.

  2019cites this paper
• MicroRNAs derived from urinary exosomes act as novel biomarkers in the diagnosis of intrahepatic cholestasis of pregnancy.

  2019cites this paper
• The Role of MicroRNAs in Selected Forms of Glomerulonephritis

  2019cites this paper
• Idiopathic nephrotic syndrome and serum permeability factors: a molecular jigsaw puzzle

  2019influential citation
• Role of Extracellular Vesicles in Renal Inflammation and Fibrosis.

  2019cites this paper
• Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus

  2019cites this paper
• Urinary Exosome-Derived microRNAs Reflecting the Changes in Renal Function in Cats

  2018cites this paper
• MicroRNA expression profile of urinary exosomes in Type IV lupus nephritis complicated by cellular crescent

  2018cites this paper
• Plasma miR‐17, miR‐20a, miR‐20b and miR‐122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients

  2018cites this paper
• Differential expression of urinary exosomal microRNAs in IgA nephropathy

  2018cites this paper
• New insight into the role of extracellular vesicles in kidney disease

  2018cites this paper
• [Urinary biomarkers for chronic kidney disease: a focus on gene transcript].

  2018cites this paper
• Genomic approaches in the search for molecular biomarkers in chronic kidney disease

  2018cites this paper
• Urinary exosome-derived microRNAs reflecting the changes of renal function and histopathology in dogs

  2017cites this paper
• Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy.

  2017cites this paper
• Urinary Biomarkers for Chronic Kidney Disease with a Focus on Gene Transcript

  2017cites this paper
• Identification of miR-16 as an endogenous reference gene for the normalization of urinary exosomal miRNA expression data from CKD patients

  2017cites this paper
• Tissue-Specific MicroRNA Expression Patterns in Four Types of Kidney Disease.

  2017cites this paper
• Cytoplasmic Localization of WT1 and Decrease of miRNA-16-1 in Nephrotic Syndrome

  2017cites this paper
• Urinary Exosomal miR-193a Can Be a Potential Biomarker for the Diagnosis of Primary Focal Segmental Glomerulosclerosis in Children

  2017cites this paper
• MicroRNAs as Master Regulators of Glomerular Function in Health and Disease.

  2017cites this paper
• Exosomes in Critical Illness

  2017cites this paper
• Regulation of the prorenin - angiotensin system by oxygen and miRNAs; parallels between placentation and tumour development?

  2017cites this paper
• Urine Exosomes: An Emerging Trove of Biomarkers.

  2017cites this paper
• Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease

  2017cites this paper
• Urinary extracellular vesicles. A promising shortcut to novel biomarker discoveries

  2017cites this paper
• MicroRNAs associated with the development of kidney diseases in humans and animals

  2017cites this paper
• Comparative analysis of EV isolation procedures for miRNAs detection in serum samples

  2016cites this paper
• Primary focal segmental glomerulosclerosis: miRNAs and targeted therapies

  2016cites this paper
• Urinary extracellular vesicles for RNA extraction: optimization of a protocol devoid of prokaryote contamination

  2016cites this paper
• Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients

  2016cites this paper